Dual-Tracer Imaging on a Long-Axial-Field-of-View PET: A Proof-of-Principle Study with [<sup>18</sup>F]FGln and [<sup>18</sup>F]FDG.
Where this comes from
- Record sourced from PubMed, PMID 40506235.
- Also identified by DOI 10.2967/jnumed.124.268831 and PMC identifier 12212401.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Current protocols necessitate imaging 2 <sup>18</sup>F-labeled tracers in separate sessions. Herein, we report on the development and testing of a protocol that sequentially images 2 <sup>18</sup>F-labeled tracers-<sup>18</sup>F-(2<i>S,</i>4<i>R</i>)4-fluoroglutamine, commonly known as [<sup>18</sup>F]FGln, and [<sup>18</sup>F]FDG-in a single session on a long-axial-field-of-view PET scanner to study cancer metabolism. <b>Methods:</b> A single [<sup>18</sup>F]FGln scan was used to estimate the minimal injected activity and scan duration to calculate an accurate volume of distribution. This was followed by a dual-tracer study in a second patient with a low-dose (41-MBq), shortened (29-min) [<sup>18</sup>F]FGln scan, followed by a full-dose (394-MBq) [<sup>18</sup>F]FDG scan for 60 min. Protocol performance was assessed using the resulting kinetic parameters. <b>Results:</b> [<sup>18</sup>F]FGln subsampling demonstrated stable estimates of volume of distribution with a scan duration of 30 min and a dose of 37 MBq. The dual-tracer [<sup>18</sup>F]FDG image obtained 60 min after injection was of diagnostic quality, with minimal (6%) residual [<sup>18</sup>F]FGln signal. <b>Conclusion:</b> This proof-of-principle dual-tracer study demonstrated the feasibility of a [<sup>18</sup>F]FGln/[<sup>18</sup>F]FDG protocol that leveraged the high sensitivity of long-axial-field-of-view PET to inject the first tracer at a low dose and the second tracer at a greater dose, overwhelming the signal from the first tracer.
Medical subject headings
- Fluorodeoxyglucose F18
- Positron-Emission Tomography